A recent study which aimed to evaluate the effect of an IL-1R1 receptor Inhibitor (Anakinra) on lowering the blood pressure in patients with obesity suggested Anakinra could significantly lower the systolic blood pressure and peripheral vascular resistance (104), which supported that the IL-1β could affect the progression of hypertension. The gene discussed is IL1B; the disease is Hypertension.